Market Overview

LifePoint Health to Merge with RCCH HealthCare Partners

Share:

LifePoint Shareholders to Receive $65.00 per Share in Cash

Privately Held Combined Company to Operate as LifePoint Health

LifePoint Health, Inc. (NASDAQ:LPNT) ("LifePoint") and RCCH HealthCare
Partners ("RCCH"), which is owned by certain funds managed by affiliates
of Apollo Global Management, LLC (NYSE:APO) (together with its
consolidated subsidiaries, "Apollo"), today announced that they have
entered into a definitive agreement to merge. Upon closing of the
transaction, LifePoint shareholders will receive $65.00 per share in
cash for each share of LifePoint common stock they own, resulting in a
LifePoint enterprise value of approximately $5.6 billion, including $2.9
billion of net debt and minority interest. The purchase price represents
a premium of approximately 36% to LifePoint's closing share price on
July 20, 2018, the last trading day prior to the announcement.

Upon completion of the transaction, the combined company will be
privately held, operate under the LifePoint Health name and be led by
William F. Carpenter III, chairman and chief executive officer of
LifePoint.

LifePoint and RCCH are among the nation's leading healthcare providers,
owning and operating networks of hospitals, post-acute service providers
and outpatient centers that are integral to their communities. Both
companies share a commitment to providing high quality care to regional
markets. The combination of these two companies will create an even
stronger healthcare provider with pro forma 2017 revenues of more than
$8 billion as well as 7,000 affiliated physicians, approximately 60,000
employees and more than 12,000 licensed beds. Following the close of the
transaction, LifePoint will operate a diversified portfolio of
healthcare assets, including 84 non-urban hospitals in 30 states,
regional health systems, physician practices, outpatient centers and
post-acute service providers, with leading market positions as the sole
community healthcare provider in the majority of the regions it serves.
The combined company intends to maintain strategic partnerships with
well-known leaders in patient safety and clinical quality to bring
leading practices in quality and patient safety to each of its
communities.

William F. Carpenter III, chairman and chief executive officer of
LifePoint, said, "LifePoint and RCCH are aligned in our missions and
commitment to ensuring that non-urban communities across the country
have access to quality care, close to home. Together, we can extend this
shared focus while generating new opportunities for growth and
partnerships that will help us navigate the changing healthcare industry
dynamics. I am eager to work with the outstanding teams at LifePoint and
RCCH as we continue advancing high quality patient care and Making
Communities Healthier."

Martin Rash, chairman and chief executive officer of RCCH, said, "The
opportunity to join with LifePoint marks a significant milestone in
RCCH's history. The size, scale and focus on growth for the new
organization will be impactful for our patients, employees and partners.
I am thrilled that these two great companies are coming together."

Matthew Nord, a senior partner at Apollo, said, "We are excited that
LifePoint and RCCH are combining to create a national leader in
community-based healthcare, and are looking forward to the next chapter
of the combined company's growth."

Following the close of the transaction, the combined company will be
named LifePoint Health, and the company's headquarters will continue to
be in Brentwood, TN, where both companies' headquarters are currently
located.

The transaction is expected to be completed over the course of the next
several months, subject to customary closing conditions, including
approval by LifePoint's shareholders and receipt of applicable
regulatory approvals.

Under the terms of the definitive agreement, which has been unanimously
approved by the LifePoint Board of Directors, LifePoint may actively
solicit alternative acquisition proposals during a 30-day period
following the execution date of the definitive agreement, continuing
until 12:01 a.m. ET on August 22, 2018. There can be no assurances that
this process will result in a superior proposal, and LifePoint does not
intend to discuss any developments with regard to this process unless
and until the LifePoint Board of Directors makes a decision with respect
to any potential superior proposal.

Financing is being provided by Barclays, Citigroup, RBC Capital Markets
and Credit Suisse. PSP Investments Credit USA LLC and an affiliate of
Qatar Investment Authority have also committed to provide a portion of
the debt financing. The financing also includes an equity contribution
from funds managed by Apollo.

Goldman Sachs & Co. LLC is acting as financial advisor to LifePoint and
White & Case LLP is acting as legal advisor. Barclays and MTS Health
Partners, L.P. are acting as financial advisors to RCCH, and Akin Gump
Strauss Hauer & Feld LLP and Paul, Weiss, Rifkind, Wharton & Garrison
LLP are acting as legal advisors.

About LifePoint

LifePoint Health is a leading healthcare company dedicated to Making
Communities Healthier®. Through its subsidiaries, it provides quality
inpatient, outpatient and post-acute services close to home. LifePoint
owns and operates community hospitals, regional health systems,
physician practices, outpatient centers, and post-acute facilities in 22
states. It is the sole community healthcare provider in the majority of
the non-urban communities it serves. More information about the Company
can be found at www.LifePointHealth.net.
All references to "LifePoint," "LifePoint Health" or the "Company" used
in this release refer to affiliates or subsidiaries of LifePoint Health,
Inc.

About RCCH

RCCH HealthCare Partners works with communities to build strong regional
healthcare systems that are known for quality patient care. Based in
Brentwood, Tennessee, RCCH HealthCare Partners operates 16 regional
health systems in 12 states. RCCH HealthCare Partners has more than
14,000 employees and 2,500 affiliated physicians and mid-level
providers. For more information, visit www.RCCHHealth.com.

About Apollo

Apollo is a leading global alternative investment manager with offices
in New York, Los Angeles, Houston, Bethesda, London, Frankfurt, Madrid,
Luxembourg, Mumbai, Delhi, Singapore, Hong Kong and Shanghai. Apollo had
assets under management of approximately $247 billion as of March 31,
2018 in credit, private equity, and real assets funds invested across a
core group of nine industries where Apollo has considerable knowledge
and resources. For more information about Apollo, please visit www.apollo.com.

Additional Information and Where to Find It

This communication relates to the proposed merger transaction involving
LifePoint. In connection with the proposed merger, LifePoint plans to
file with the Securities and Exchange Commission (the "SEC") preliminary
and definitive proxy statements and other relevant documents. This
communication is not a substitute for the proxy statement or any other
document that LifePoint may file with the SEC or send to its
stockholders in connection with the proposed merger. BEFORE MAKING ANY
VOTING DECISION, STOCKHOLDERS OF LIFEPOINT ARE URGED TO READ ALL
RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING THE PROXY STATEMENT,
WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT
INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security
holders will be able to obtain the proxy statement and other documents
filed by LifePoint with the SEC (when available) free of charge at the
SEC's website, http://www.sec.gov,
and LifePoint's website, www.lifepointhealth.net.

Participants in the Solicitation

LifePoint and its directors and executive officers may be deemed to be
participants in the solicitation of proxies from the holders of
LifePoint common stock in respect of the proposed transaction.
Information about the directors and executive officers of LifePoint is
set forth in LifePoint's Annual Report on Form 10-K for the year ended
December 31, 2017, filed with the SEC on February 23, 2018 and proxy
statement for its 2018 annual meeting of stockholders, filed with the
SEC on April 25, 2018. Additional information regarding potential
participants in the proxy solicitation and a description of their direct
and indirect interests, by security holdings or otherwise, will be
contained in the proxy statement and other relevant documents to be
filed by LifePoint with the SEC in respect of the proposed transaction.

Forward-Looking Statements

This communication contains certain information, including statements as
to the expected timing, completion and effects of the proposed merger
involving LifePoint, which may constitute forward-looking statements
within the meaning of the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Such forward-looking
statements are subject to risks and uncertainties, and actual results
may differ materially. Such forward looking statements include, among
others, statements about the benefits of the proposed transaction,
including future financial and operating results, plans, objectives,
expectations for LifePoint and other statements that are not historical
facts. Such statements are based on the current beliefs and expectations
of the management of LifePoint and are subject to significant risks and
uncertainties outside of LifePoint's control. These risks and
uncertainties include the possibility that the anticipated benefits from
the proposed transaction will not be realized, or will not be realized
within the expected time periods; the occurrence of any event, change or
other circumstances that could give rise to termination of the proposed
transaction agreement; the failure of LifePoint's stockholders to adopt
the merger agreement; operating costs, loss and business disruption
(including, without limitation, difficulties in maintaining
relationships with employees, customers or suppliers) may be greater
than expected following the announcement of the proposed transaction;
the retention of certain key employees at LifePoint; risks associated
with the disruption of management's attention from ongoing business
operations due to the proposed transaction; the inability to obtain
necessary regulatory approvals of the proposed transaction or the
receipt of such approvals subject to conditions that are not
anticipated; the risk that a condition to closing the transaction may
not be satisfied on a timely basis or at all; the risk that the proposed
transaction fails to close for any other reason; the outcome of any
legal proceedings related to the proposed transaction; the parties'
ability to meet expectations regarding the timing and completion of the
proposed transaction; the impact of the proposed transaction on
LifePoint's credit rating; and other risks described in LifePoint's Form
10- K, Form 10-Q and Form 8-K reports filed with the SEC. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. Except as otherwise
required by law, LifePoint does not undertake any obligation, and
expressly disclaims any obligation, to update, alter or otherwise revise
any forward-looking statements, whether written or oral, that may be
made from time to time, whether as a result of new information, future
events or otherwise.

View Comments and Join the Discussion!